Skip to main content
. 2004 Jan 24;328(7433):192. doi: 10.1136/bmj.328.7433.192

Table 2.

Pregnancy outcomes at 12 months in 83 women allocated to electrocautery strategy and 85 allocated to ovulation induction with recombinant follicle stimulating hormone. Values are numbers (percentages) of women

Treatment regimen No of women Pregnant No of miscarriages* No of multiple pregnancies Ongoing pregnancy No of premature deliveries Live births
Electrocautery strategy:
Electrocautery 83 (100) 31 (37) 3 28 (34) 28 (34)
Electrocautery and clomiphene citrate 45 (54) 14 (31) 1 13 (29) 13 (29)
Electrocautery, clomiphene citrate, and recombinant follicle stimulating hormone 23 (28) 18 (78) 3 1 15 (65) 3 12 (52)
Electrocautery strategy: total 83 63 (76) 7 1 56 (67) 3 53 (64)
Recombinant follicle stimulating hormone 85 64 (75) 7 9 57 (67) 6 51 (60)
*

<12 weeks.

Includes one ectopic pregnancy.